Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, Mark Kaminski et al.|Journal of Clinical Oncology|2013Cited by 439
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research ReportHaesook T. Kim, Michael R. Grunwald, Kwang Woo Ahn et al.|Clinical Cancer Research|2019Cited by 13
Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes RegistryRachel Cusatis, Bronwen E. Shaw, Kathryn E. Flynn et al.|Transplantation and Cellular Therapy|2021Cited by 13